Positive and negative functions of B lymphocytes in tumors

Meng Shen; Qian Sun; Jian Wang; Wei Pan; Xiubao Ren

doi:10.18632/oncotarget.10094

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Reviews:

Positive and negative functions of B lymphocytes in tumors

Meng Shen, Qian Sun, Jian Wang, Wei Pan and Xiubao Ren _

PDF | HTML | How to cite

Oncotarget. 2016; 7:55828-55839. https://doi.org/10.18632/oncotarget.10094

Metrics: PDF 3935 views | HTML 3389 views | ?

Abstract

Meng Shen1,3,4, Qian Sun1,3,4, Jian Wang1,3,4, Wei Pan1,3,4 and Xiubao Ren2,3,4

1 Department of Immunology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China

2 Department of Biotherapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China

3 National Clinical Research Center of Cancer, Tianjin, China

4 Key Laboratory of Cancer Immunology and Biotherapy, Tianjin, China

Correspondence to:

Xiubao Ren, email:

Keywords: B lymphocytes, regulatory B cells, tumor-infiltrating B cells, tumor, tumor immunotherapy

Received: January 22, 2016 Accepted: June 04, 2016 Published: June 15, 2016

Abstract

Accumulating evidence indicated that B lymphocytes exerted complex functions in tumor immunity. On the one hand, B lymphocytes can inhibit tumor development through antibody generation, antigen presentation, tumor tissue interaction, and direct killing. On the other hand, B lymphocytes have tumor-promoting functions. A typical type of B lymphocytes, termed regulatory B cells, is confirmed to attenuate immune response in a tumor environment. In this paper, we summarize the current understanding of B-cell functions in tumor immunology, which may shed light on potential therapeutic strategies against cancer.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 10094

Publication Alerts

Post-Publication Promotion

Publication Discount

Reviews:

Positive and negative functions of B lymphocytes in tumors

Abstract